Former strippers now employed as sales reps giving lap dances to prestigious doctors. Social gatherings disguised as educational opportunities catered with exquisite food. These are just a few of the many crooked marketing tactics Insys Therapeutics Inc. is denying having been a part of. Instead of owning up to his actions, John Kapoor, Founder of Insys, continues to deny all allegations and has decided to take the easy way out and pay up to $225 million in order to settle the federal investigation.
Massachusetts U.S. Attorney Andrew Lelling stated, “For years, Insys engaged in prolonged, illegal conduct that prioritized its profits over the health of the thousands of patients who relied on it.” Through methods of bribery, Kapoor and four former executives of the company convinced doctors across the country to prescribe the drug known as Subsys. Subsys is the spray formula of fentanyl which is designed to alleviate severe pain for patients suffering with cancer. Although Subsys makes up a small fraction of the prescription opioid crisis, Insys is facing extreme charges for their actions.
The company will pay a $2 million-dollar criminal fine, forfeit $28 million, and pay $195 million in order to settle the civil allegations. “Paying bribes and providing other incentives to prescribe opioids with little regard to patient welfare surely signals a company is more concerned with profits than patients,” Christian J. Schrank, Special Agent in Charge for the Office of Inspector General of the U.S. Department of Health and Human Services stated.
While Kapoor’s attorney is going to “continue to fight to clear Dr. Kapoor’s name,” the company will be held as an example in order to target other big businesses that are responsible for this horrific epidemic.